Literature DB >> 29262322

SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing.

Linlin Chen1, Chunling Luo1, Lei Shen2, Yuguo Liu1, Qianqian Wang1, Chang Zhang1, Ruochen Guo1, Yanan Zhang1, Zhiqin Xie1, Ning Wei1, Wenwu Wu3, Jun Han4, Ying Feng5.   

Abstract

Dysregulated alternative splicing events have been implicated in many types of cancer, but the underlying molecular mechanisms remain unclear. Here, we observe that the splicing factor SRSF1 regulates DBF4B exon6 splicing by specifically binding and promoting its inclusion. Knockdown of the exon6-containing isoform (DBF4B-FL) significantly inhibits the tumorigenic potential of colon cancer cells in vitro and in mice, and SRSF1 inactivation phenocopies DBF4B-FL depletion. DBF4B-FL and SRSF1 are required for cancer cell proliferation and for the maintenance of genomic stability. Overexpression of DBF4B-FL can protect against DNA damage induced by SRSF1 knockdown and rescues growth defects in SRSF1-depleted cells. Increased DBF4B exon6 inclusion parallels SRSF1 upregulation in clinical colorectal cancer samples. Taken together, our findings identify SRSF1 as a key regulator of DBF4B pre-mRNA splicing dysregulation in colon cancer, with possible clinical implications as candidate prognostic factors in cancer patients.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29262322     DOI: 10.1016/j.celrep.2017.11.091

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  25 in total

Review 1.  RNA-biology ruling cancer progression? Focus on 3'UTRs and splicing.

Authors:  Ayse Elif Erson-Bensan
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 2.  Gene Regulatory Network Perturbation by Genetic and Epigenetic Variation.

Authors:  Yongsheng Li; Daniel J McGrail; Juan Xu; Gordon B Mills; Nidhi Sahni; Song Yi
Journal:  Trends Biochem Sci       Date:  2018-06-22       Impact factor: 13.807

3.  Cell division cycle 7 is a potential therapeutic target in oral squamous cell carcinoma and is regulated by E2F1.

Authors:  Shufang Jin; Hailong Ma; Wenyi Yang; Houyu Ju; Lizhen Wang; Zhiyuan Zhang
Journal:  J Mol Med (Berl)       Date:  2018-04-30       Impact factor: 4.599

4.  Gene Expression and RNA Splicing Imputation Identifies Novel Candidate Genes Associated with Osteoporosis.

Authors:  Yong Liu; Hui Shen; Jonathan Greenbaum; Anqi Liu; Kuan-Jui Su; Li-Shu Zhang; Lei Zhang; Qing Tian; Hong-Gang Hu; Jin-Sheng He; Hong-Wen Deng
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

Review 5.  The role of RNA processing and regulation in metastatic dormancy.

Authors:  Kimberly A Parker; Nathaniel J Robinson; William P Schiemann
Journal:  Semin Cancer Biol       Date:  2021-03-26       Impact factor: 15.707

6.  Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.

Authors:  Jun-Xian Du; Yi-Hong Luo; Si-Jia Zhang; Biao Wang; Cong Chen; Gui-Qi Zhu; Ping Zhu; Cheng-Zhe Cai; Jing-Lei Wan; Jia-Liang Cai; Shi-Ping Chen; Zhi Dai; Wei Zhu
Journal:  J Exp Clin Cancer Res       Date:  2021-05-15

7.  The Splicing Factor SF2 Is Critical for Hyperproliferation and Survival in a TORC1-Dependent Model of Early Tumorigenesis in Drosophila.

Authors:  Malgorzata Maria Parniewska; Hugo Stocker
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

8.  Loss of SRSF2 triggers hepatic progenitor cell activation and tumor development in mice.

Authors:  Chang Zhang; Lei Shen; Wei Yuan; Yuguo Liu; Ruochen Guo; Yangjun Luo; Zheng Zhan; Zhiqin Xie; Guohao Wu; Wenwu Wu; Ying Feng
Journal:  Commun Biol       Date:  2020-05-05

Review 9.  RNA-binding proteins in tumor progression.

Authors:  Hai Qin; Haiwei Ni; Yichen Liu; Yaqin Yuan; Tao Xi; Xiaoman Li; Lufeng Zheng
Journal:  J Hematol Oncol       Date:  2020-07-11       Impact factor: 17.388

10.  Extracellular matrix stiffness controls VEGF165 secretion and neuroblastoma angiogenesis via the YAP/RUNX2/SRSF1 axis.

Authors:  Min Bao; Yi Chen; Ji-Ting Liu; Han Bao; Wen-Bin Wang; Ying-Xin Qi; Fan Lv
Journal:  Angiogenesis       Date:  2021-06-25       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.